Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.
复制标题
DOI:
10.4049/jimmunol.0902318
复制
发表时间:
2009-12-15
期刊:
影响因子:
--
通讯作者:
Le AD
中科院分区:
文献类型:
--
作者:
Zhang Q;Shi S;Liu Y;Uyanne J;Shi Y;Shi S;Le AD
Aside from the well-established self-renewal and multipotent differentiation properties, mesenchymal stem cells exhibit both immunomodulatory and anti-inflammatory roles in several experimental autoimmune and inflammatory diseases. In this study, we isolated a new population of stem cells from human gingiva, a tissue source easily accessible from the oral cavity, namely, gingiva-derived mesenchymal stem cells (GMSCs), which exhibited clonogenicity, self-renewal, and multipotent differentiation capacities. Most importantly, GMSCs were capable of immunomodulatory functions, specifically suppressed peripheral blood lymphocyte proliferation, induced expression of a wide panel of immunosuppressive factors including IL-10, IDO, inducible NO synthase (iNOS), and cyclooxygenase 2 (COX-2) in response to the inflammatory cytokine, IFN-γ. Cell-based therapy using systemic infusion of GMSCs in experimental colitis significantly ameliorated both clinical and histopathological severity of the colonic inflammation, restored the injured gastrointestinal mucosal tissues, reversed diarrhea and weight loss, and suppressed the overall disease activity in mice. The therapeutic effect of GMSCs was mediated, in part, by the suppression of inflammatory infiltrates and inflammatory cytokines/mediators and the increased infiltration of regulatory T cells and the expression of anti-inflammatory cytokine IL-10 at the colonic sites. Taken together, GMSCs can function as an immunomodulatory and anti-inflammatory component of the immune system in vivo and is a promising cell source for cell-based treatment in experimental inflammatory diseases.
登录
查看更多内容
影响因子:
--
作者:
Gonzalez, Manuel A.;Gonzalez-Rey, Elena;Delgado, Mario
通讯作者:
Delgado, Mario
影响因子:
4.4
作者:
Haniffa, Muzlifah A.;Wang, Xiao-Nong;Collin, Matthew P.
通讯作者:
Collin, Matthew P.
影响因子:
2.6
作者:
Covas, Dimas T.;Panepucci, Rodrigo A.;Zago, Marco A.
通讯作者:
Zago, Marco A.
影响因子:
5.2
作者:
Chang, Chun-Jung;Yen, Men-Luh;Yen, B. Linju
通讯作者:
Yen, B. Linju
影响因子:
20.3
作者:
Beltrami, Antonio R.;Cesselli, Daniela;Beltrami, Carlo A.
通讯作者:
Beltrami, Carlo A.